歐洲的整形外科用生技材料市場：2011年

歐洲的整形外科用生技材料市場：2011年 是由出版商iData Research Inc.在2011年05月所出版的。 這份英文市場調查報告書包含318 Pages 價格從美金10995起跳。

簡介

歐洲的整形外科用生技材料市場到2017年為止擴大至10億歐元的規模。此市場中玻尿酸關節節内補充療法(Hyaluronic Acid Viscosupplementation)市場占最大的佔有率。

本報告書內容包括:歐洲的整形外科醫用生技材料市場（骨移植片替代物及玻尿酸關節内補充療法等）的調查、市場的現況和2017年為止的未來預測、各分類趨勢分析、銷售件數・單價、各國介紹、競争結構、產品線揭幕等資訊、內容綱要摘記如下:

第1章　實施摘要

第2章　分析方法

第3章　歐洲的整形外科用生技材料：概要

• 介紹
• 匯率
• 市場概要
• 各水泥市場
• 各水泥傾向分析
• 各國市場
• 市場促進・抑制因素
• 市場競爭圖
• 企業收購・合併

第4章　各國介紹

• 介紹
• 德國
• 法國
• 英國
• 西班牙
• 義大利
• 荷比盧各國
• 斯堪的納維亞各國
• 瑞士
• 奧地利
• 葡萄牙
• 希臘

第5章　骨移植片替代物市場

• 介紹
• 市場概要
• 市場分析・預測
• DBM（脫鹽水骨基質）市場
• 市場促進・抑制因素
• 市場競爭圖

第6章　BPM（骨誘導蛋白質）增殖因子療法市場

• 介紹
• 市場分析・預測
• 市場促進・抑制因素
• 市場競爭圖

第7章　玻尿酸關節内補充療法市場

• 介紹
• 市場概要
• 市場分析・預測
• 市場促進・抑制因素
• 市場競爭圖

第8章　自己軟骨細胞移植市場

• 介紹
• 市場分析・預測
• 市場促進・抑制因素
• 市場競爭圖

簡略語集

附錄：骨用水泥市場

圖表一覽

目錄

Abstract

The European orthopedic biomaterials markets are expected to approach € 1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment.

The European orthopedic biomaterials markets include:

• autologous bone grafts,
• bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
• hyaluronic acid (HA) viscosupplementation,
• bone morphogenetic protein (BMP) growth factor therapy
• autologous chondrocyte implantation (ACI)

The European markets include:

• Germany,
• France,
• the United Kingdom,
• Spain,
• Italy,
• Benelux (Belgium, the Netherlands and Luxembourg),
• Scandinavia (Denmark, Finland, Norway and Sweden),
• Switzerland,
• Austria,
• Portugal and
• Greece

The ACI market grew most rapidly in 2010 at a rate of nearly 12%, followed by the BGS market. Within the European orthopedic biomaterials market, companies such as Fidia, Genzyme, Rottapharm/Madaus and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• 1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS
• 1.2 AUTOGRAFTED BONE PROCEDURES
• 1.3 BONE GRAFT SUBSTITUTE MARKET
• 1.4 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
• 1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
• 1.6 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
• 1.7 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

• 3.1 INTRODUCTION
  • 3.1.1 Products
    • 3.1.1.1 Growth Factors
    • 3.1.1.2 Bone Graft Substitutes
    • 3.1.1.3 Hyaluronic Acid Viscosupplementation
    • 3.1.1.4 Autologous Chondrocyte Implantation
• 3.2 CURRENCY EXCHANGE RATE
• 3.3 MARKET OVERVIEW
• 3.4 MARKET BY SEGMENT
• 3.5 TREND ANALYSIS BY SEGMENT
• 3.6 MARKET BY COUNTRY
• 3.7 MARKET DRIVERS AND LIMITERS
  • 3.7.1 Market Drivers
  • 3.7.2 Market Limiters
• 3.8 COMPETITIVE ANALYSIS
  • 3.8.1 Market Concentration
• 3.9 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

• 4.1 INTRODUCTION
  • 4.1.1 Population
  • 4.1.2 GDP per Capita
  • 4.1.3 Procedures
  • 4.1.4 Price Index
• 4.2 GERMANY
• 4.3 FRANCE
• 4.4 UNITED KINGDOM
• 4.5 SPAIN
• 4.6 ITALY
• 4.7 BENELUX
• 4.8 SCANDINAVIA
• 4.9 SWITZERLAND
• 4.10 AUSTRIA
• 4.11 PORTUGAL
• 4.12 GREECE

BONE GRAFT SUBSTITUTE MARKET

• 5.1 INTRODUCTION
  • 5.1.1 Volumes Represented per Procedure
• 5.2 MARKET OVERVIEW
  • 5.2.1 Total Bone Graft Substitute Procedures by Indication
  • 5.2.2 Total Bone Graft Substitute Procedures by Segment
  • 5.2.3 Bone Graft Substitute Average Selling Price by Segment
  • 5.2.4 Bone Graft Substitute Market by Segment
• 5.3 MARKET ANALYSIS AND FORECAST
  • 5.3.1 Total Bone Graft Substitute Market
  • 5.3.2 Total Allograft Market
    • 5.3.2.1 Allograft Spine Market
    • 5.3.2.2 Allograft Cervical Spine Market
    • 5.3.2.3 Allograft Thoracolumbar Spine Market
    • 5.3.2.4 Allograft Trauma and Reconstruction Market
    • 5.3.2.5 Allograft Craniomaxillofacial Market
  • 5.3.3 Total Synthetic Material Market
    • 5.3.3.1 Synthetic Spine Market
    • 5.3.3.2 Synthetic Cervical Spine Market
    • 5.3.3.3 Synthetic Thoracolumbar Spine Market
    • 5.3.3.4 Synthetic Trauma and Reconstruction Market
    • 5.3.3.5 Synthetic Craniomaxillofacial Market
  • 5.3.4 Total DBM Market
    • 5.3.4.1 DBM Spine Market
    • 5.3.4.2 DBM Cervical Spine Market
    • 5.3.4.3 DBM Thoracolumbar Spine Market
    • 5.3.4.4 DBM Trauma and Reconstruction Market
    • 5.3.4.5 DBM Craniomaxillofacial Market
• 5.4 MARKET DRIVERS AND LIMITERS
  • 5.4.1 Market Drivers
  • 5.4.2 Market Limiters
• 5.5 COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

• 6.1 INTRODUCTION
• 6.2 MARKET ANALYSIS AND FORECAST
• 6.3 MARKET DRIVERS AND LIMITERS
  • 6.3.1 Market Drivers
  • 6.3.2 Market Limiters
• 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 7.1 INTRODUCTION
• 7.2 MARKET OVERVIEW
• 7.3 MARKET ANALYSIS AND FORECAST
  • 7.3.1 Total Hyaluronic Acid Viscosupplementation Market
  • 7.3.2 Single-Injection Market
  • 7.3.3 Three-Injection Cycle Market
  • 7.3.4 Five-Injection Cycle Market
• 7.4 MARKET DRIVERS AND LIMITERS
  • 7.4.1 Market Drivers
  • 7.4.2 Market Limiters
• 7.5 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• 8.1 INTRODUCTION
• 8.2 MARKET ANALYSIS AND FORECAST
• 8.3 MARKET DRIVERS AND LIMITERS
  • 8.3.1 Market Drivers
  • 8.3.2 Market Limiters
• 8.4 COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

• 10.1 BONE CEMENT MARKET ANALYSIS AND FORECAST

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

• Figure 3-1: Exchange Rate between Selected European Currencies and the Euro, 2010
• Figure 3-2: Total European Orthopedic Biomaterials Market, Europe, 2007 - 2017
• Figure 3-3: Total Orthopedic Biomaterials Market, Europe, 2007 - 2017 (€ M)
• Figure 3-4: Total Orthopedic Biomaterials Market, Europe, 2007 - 2017 (US$M)
• Figure 3-5: Orthopedic Biomaterials Market Growth Rates by Segment, Europe, 2007 - 2017
• Figure 3-6: Orthopedic Biomaterials Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 3-7: Orthopedic Biomaterials Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 3-8: Market Drivers and Limiters, Orthopedic Biomaterials Market, Europe, 2010
• Figure 3-9: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2010
• Figure 3-10: Market Concentration, Orthopedic Biomaterials Market, Europe, 2010

COUNTRY PROFILES

• Figure 4-1: European Price Index for BGS Materials by Country, 2010

BONE GRAFT SUBSTITUTE MARKET

• Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Europe, 2007 - 2017
• Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2007 - 2017
• Figure 5-3: Bone Graft Substitute ASP by Segment, Europe, 2007 - 2017 (€ )
• Figure 5-4: Bone Graft Substitute ASP by Segment, Europe, 2007 - 2017 (US$)
• Figure 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (€ M)
• Figure 5-6: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (US$M)
• Figure 5-7: Total Bone Graft Substitute Procedures by Country, Europe, 2007 - 2017
• Figure 5-8: Total Bone Graft Substitute Units Sold by Country, Europe, 2007 - 2017
• Figure 5-9: Total Bone Graft Substitute ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-10: Total Bone Graft Substitute ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-11: Total Bone Graft Substitute Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-12: Total Bone Graft Substitute Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-13: Total Bone Graft Substitute Market, Europe, 2007 - 2017 (€ M)
• Figure 5-14: Total Allograft Procedures by Country, Europe, 2007 - 2017
• Figure 5-15: Total Allograft Units Sold by Country, Europe, 2007 - 2017
• Figure 5-16: Total Allograft ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-17: Total Allograft ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-18: Total Allograft Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-19: Total Allograft Market by Country, Europe, 2007-2017 (US$M)
• Figure 5-20: Allograft Total Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-21: Allograft Total Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-22: Allograft Total Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-23: Allograft Total Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-24: Allograft Total Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-25: Allograft Total Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-26: Allograft Cervical Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-27: Allograft Cervical Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-28: Allograft Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-29: Allograft Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-30: Allograft Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-31: Allograft Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-32: Allograft Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-33: Allograft Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-34: Allograft Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-35: Allograft Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-36: Allograft Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-37: Allograft Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-38: Allograft Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
• Figure 5-39: Allograft Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
• Figure 5-40: Allograft Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-41: Allograft Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-42: Allograft Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-43: Allograft Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-44: Allograft Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
• Figure 5-45: Allograft Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
• Figure 5-46: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-47: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-48: Allograft Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-49: Allograft Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-50: Total Synthetic Procedures by Country, Europe, 2007 - 2017
• Figure 5-51: Total Synthetic Units Sold by Country, Europe, 2007 - 2017
• Figure 5-52: Total Synthetic ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-53: Total Synthetic ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-54: Total Synthetic Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-55: Total Synthetic Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-56: Synthetic Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-57: Synthetic Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-58: Synthetic Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-59: Synthetic Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-60: Synthetic Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-61: Synthetic Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-62: Synthetic Cervical Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-63: Synthetic Cervical Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-64: Synthetic Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-65: Synthetic Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-66: Synthetic Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-67: Synthetic Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-68: Synthetic Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-69: Synthetic Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-70: Synthetic Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-71: Synthetic Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-72: Synthetic Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-73: Synthetic Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-74: Synthetic Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
• Figure 5-75: Synthetic Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
• Figure 5-76: Synthetic Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-77: Synthetic Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-78: Synthetic Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-79: Synthetic Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-80: Synthetic Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
• Figure 5-81: Synthetic Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
• Figure 5-82: Synthetic Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-83: Synthetic Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-84: Synthetic Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-85: Synthetic Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-86: Total DBM Procedures by Country, Europe, 2007 - 2017
• Figure 5-87: Total DBM Units Sold by Country, Europe, 2007 - 2017
• Figure 5-88: Total DBM ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-89: Total DBM ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-90: Total DBM Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-91: Total DBM Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-92: DBM Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-93: DBM Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-94: DBM Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-95: DBM Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-96: DBM Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-97: DBM Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-98: DBM Cervical Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-99: DBM Cervical Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-100: DBM Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-101: DBM Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-102: DBM Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-103: DBM Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-104: DBM Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
• Figure 5-105: DBM Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
• Figure 5-106: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-107: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-108: DBM Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-109: DBM Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-110: DBM Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
• Figure 5-111: DBM Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
• Figure 5-112: DBM Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-113: DBM Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-114: DBM Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-115: DBM Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-116: DBM Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
• Figure 5-117: DBM Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
• Figure 5-118: DBM Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 5-119: DBM Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 5-120: DBM Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 5-121: DBM Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 5-122: Drivers and Limiters, Bone Graft Substitute Market, Europe, 2007 - 2017
• Figure 5-123: Leading Competitors, Bone Graft Substitute Market by Country, Europe, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

• Figure 6-1: Bone Morphogenetic Protein Growth Factor Units (Vials), Europe, 2007 - 2017
• Figure 6-2: Bone Morphogenetic Protein Growth Factor ASP, Europe, 2007 - 2017 (€ )
• Figure 6-3: Bone Morphogenetic Protein Growth Factor ASP, Europe, 2007 - 2017 (US$)
• Figure 6-4: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (€ M)
• Figure 6-5: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (US$M)
• Figure 6-6: Drivers and Limiters, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2007 - 2017
• Figure 6-7: Leading Competitors, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Figure 7-1: Total Hyaluronic Acid Viscosupplementation Procedures by Segment, Europe, 2007 - 2017
• Figure 7-2: Total Hyaluronic Acid Viscosupplementation ASP by Segment, Europe, 2007 - 2017 (€ )
• Figure 7-3: Total Hyaluronic Acid Viscosupplementation ASP by Segment, Europe, 2007 - 2017 (US$)
• Figure 7-4: Total Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017 (€ M)
• Figure 7-5: Total Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017 (US$M)
• Figure 7-6: Total Hyaluronic Acid Viscosupplement Injections by Country, Europe, 2007 - 2017
• Figure 7-7: Hyaluronic Acid Viscosupplementation ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 7-8: Hyaluronic Acid Viscosupplementation ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 7-9: Total Hyaluronic Acid Viscosupplementation Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 7-10: Total Hyaluronic Acid Viscosupplementation Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 7-11: Single-Injection Procedures by Country, Europe, 2007 - 2017
• Figure 7-12: Single-Injection ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 7-13: Single-Injection ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 7-14: Single-Injection Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 7-15: Single-Injection Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 7-16: Three-Injection Cycle Procedures by Country, Europe, 2007 - 2017
• Figure 7-17: Three-Injection Cycle ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 7-18: Three-Injection Cycle ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 7-19: Three-Injection Cycle Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 7-20: Three-Injection Cycle Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 7-21: Five-Injection Cycle Procedures by Country, Europe, 2007 - 2017
• Figure 7-22: Five-Injection Cycle ASP by Country, Europe, 2007 - 2017 (€ )
• Figure 7-23: Five-Injection Cycle ASP by Country, Europe, 2007 - 2017 (US$)
• Figure 7-24: Five-Injection Cycle Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 7-25: Five-Injection Cycle Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 7-26: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017
• Figure 7-27: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2010

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• Figure 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ )
• Figure 8-2: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (US$)
• Figure 8-3: Autologous Chondrocyte Implantation Units Sold by Country, Europe, 2007 - 2017
• Figure 8-4: Autologous Chondrocyte Implantation Market by Country, Europe, 2007 - 2017 (€ M)
• Figure 8-5: Autologous Chondrocyte Implantation Market by Country, Europe, 2007 - 2017 (US$M)
• Figure 8-6: Drivers and Limiters, Autologous Chondrocyte Implantation Market, Europe, 2010
• Figure 8-7: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2010

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

• Figure 10-1: Premixed Antibiotic Bone Cement Market, Europe, 2007 - 2017 (€ )
• Figure 10-2: Premixed Antibiotic Bone Cement Market, Europe, 2007 - 2017 (US$)
• Figure 10-3: Traditional Bone Cement Market, Europe, 2007-2017 (€ )
• Figure 10-4: Traditional Bone Cement Market, Europe, 2007 - 2017 (US$)
• Figure 10-5: Leading Competitors, Bone Cement Market, Europe, 2010

LIST OF CHARTS

EXECUTIVE SUMMARY

• Chart 1-1: Total Orthopedic Biomaterials Markets, Europe, 2007 - 2017 (€ M)
• Chart 1-2: Autograft Procedures, Europe, 2017
• Chart 1-3: Orthopedic Procedures by Bone Graft Substitute, Europe, 2010
• Chart 1-4: BMP Growth Factor Market, Europe, 2007 - 2017 (€ M)
• Chart 1-5: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017
• Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ M)
• Chart 1-7: Leading Competitors, Orthopedic Biomaterial Markets, Europe, 2010

RESEARCH METHODOLOGY

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

• Chart 3-1: Total European Orthopedic Biomaterials Market, Europe, 2007 - 2017 (€ M)
• Chart 3-2: Total Orthopedic Biomaterials Market by Segment, Europe, 2007 - 2017 (€ M)
• Chart 3-3: Total Orthopedic Biomaterials Market by Segment, Europe, 2010
• Chart 3-4: Total Orthopedic Biomaterials Market by Segment, Europe, 2017
• Chart 3-5: Total European Orthopedic Biomaterials Market by Segment, Europe, 2008 - 2017
• Chart 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2010

COUNTRY PROFILES

• Chart 4-1: Country Profile, Germany, 2010
• Chart 4-2: Country Profile, France, 2010
• Chart 4-3: Country Profile, U.K., 2010
• Chart 4-4: Country Profile, Spain, 2010
• Chart 4-5: Country Profile, Italy, 2010
• Chart 4-6: Country Profile, Benelux, 2010
• Chart 4-7: Country Profile, Scandinavia, 2010
• Chart 4-8: Country Profile, Switzerland, 2010
• Chart 4-9: Country Profile, Austria, 2010
• Chart 4-10: Country Profile, Portugal, 2010
• Chart 4-11: Country Profile, Greece, 2010

BONE GRAFT SUBSTITUTE MARKET

• Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Europe, 2010
• Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Europe, 2017
• Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2010
• Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2017
• Chart 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (€ M)
• Chart 5-6: Bone Graft Substitute Market by Segment, Europe, 2010
• Chart 5-7: Bone Graft Substitute Market by Segment, Europe, 2017
• Chart 5-8: Total Allograft Market, Europe, 2007 - 2017 (€ M)
• Chart 5-9: Allograft Total Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-10: Allograft Cervical Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-11: Allograft Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-12: Allograft Trauma and Reconstruction Market, Europe, 2007 - 2017 (€ M)
• Chart 5-13: Allograft Craniomaxillofacial Market, Europe, 2007 - 2017 (€ M)
• Chart 5-14: Total Synthetic Market, Europe, 2007 - 2017 (€ M)
• Chart 5-15: Synthetic Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-16: Synthetic Cervical Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-17: Synthetic Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-18: Synthetic Trauma and Reconstruction Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-19: Synthetic Craniomaxillofacial Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-20: Total DBM Market, Europe, 2007 - 2017 (€ M)
• Chart 5-21: DBM Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-22: DBM Cervical Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-23: DBM Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-24: DBM Trauma and Reconstruction Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-25: DBM Craniomaxillofacial Spine Market, Europe, 2007 - 2017 (€ M)
• Chart 5-26: Leading Competitors, Bone Graft Substitute Market by Country, Europe, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

• Chart 6-1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (€ M)
• Chart 6-2: Leading Competitors, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Chart 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
• Chart 7-2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2010
• Chart 7-3: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2017
• Chart 7-4: Total Single-Injection Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
• Chart 7-5: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
• Chart 7-6: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
• Chart 7-7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2010

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• Chart 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ M)
• Chart 8-2: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2010

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

• Chart 10-1: Leading Competitors, Bone Cement Market, Europe, 2010

相關商品

矚目市場調查報告書

全球整形外科數據庫

Global Orthopedic Procedure Volumes Database

價格 : US $ 18000

生物材料相關市場調查報告書

口腔清潔用品&牙科用消耗品市場(牙科生技材料·特殊用途產品·修復劑):目前趨勢·市場機會·全球市場預測(∼2016年)
Oral Care Products & Other Dental Consumables Market (Dental Biomaterials, Specialty Products, & Restoratives) Current Trends, Opportunities & Global Forecasts to 2016
價格 : US $ 4650
出版日期 : 2012年04月

歐洲的牙科用人工骨替代材料，牙科再生膜及再生牙科市場(21個國家):2012年
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)
價格 : US $ 10995
出版日期 : 2012年03月

生物相容性材料的全球市場
Biocompatible Materials
價格 : US $ 4500
出版日期 : 2012年02月

iData Research Inc.發行的生物科技相關市場調查報告書

美國的創傷·組織管理市場:2012年

U.S. Market for Wound and Tissue Management 2012

價格 : US $ 6995

出版日期 : 2012年02月

美國的牙科用人工骨替代材料，牙科再生膜及再生牙科產品市場:2012年

U.S. Market for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering Products 2012

價格 : US $ 6995

出版日期 : 2012年01月

美國的整形外科用軟骨組織及運動醫學市場:2011年

U.S. Market for Orthopedic Soft Tissue Repair and Sports Medicine 2011

價格 : US $ 6995

出版日期 : 2011年11月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!